These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15308057)

  • 1. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safety and immunogenicity of split vaccines of influenza viruses].
    Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Safety of an influenza-split-vaccine in children].
    Schmitt-Grohé S; Banzhoff A; Klaassen B; Zielen S
    Klin Padiatr; 2001; 213(6):338-42. PubMed ID: 11713714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
    J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 12. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian influenza serosurvey prior to the 1992-1993 season.
    Can Commun Dis Rep; 1992 Nov; 18(22):161-6. PubMed ID: 1291010
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
    Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The trivalent polymer-subunit influenza vaccine Grippol studied in a controlled epidemiological trial (1)].
    El'shina GA; Masalin IuM; Shervali VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Voen Med Zh; 1996 Aug; 317(8):57-60. PubMed ID: 9036650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of immunogenicity and safety of domestic influenza vaccines].
    Yao J; Li Q; Xu Q; Feng CF; Lu YM; Xu BQ; Lu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):735. PubMed ID: 15555412
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I.
    Ioniţă E; Lupulescu E; Alexandrescu V; Maţepiuc M; Constantinescu C; Creţescu L; Velea L
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):265-73. PubMed ID: 2519636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal DNA vaccine for influenza is immunogenic in humans.
    Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ
    Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cross immunity study of two different influenza A3 virus vaccine strain].
    Zhang ZL; Zhu XJ; Zhang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Jun; 44(6):522-5. PubMed ID: 21055127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.